Relationships between urinary biomarkers of phytoestrogens, phthalates, phenols, and pubertal stages in girls by Chakraborty, Tandra R et al.
City University of New York (CUNY) 
CUNY Academic Works 
Publications and Research New York City College of Technology 
2012 
Relationships between urinary biomarkers of phytoestrogens, 
phthalates, phenols, and pubertal stages in girls 





CUNY New York City College of Technology 
How does access to this work benefit you? Let us know! 
More information about this work at: https://academicworks.cuny.edu/ny_pubs/54 
Discover additional works at: https://academicworks.cuny.edu 
This work is made publicly available by the City University of New York (CUNY). 
Contact: AcademicWorks@cuny.edu 
© 2012 Chakraborty et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article 
which permits unrestricted noncommercial use, provided the original work is properly cited.
Adolescent Health, Medicine and Therapeutics 2012:3 17–26
Adolescent Health, Medicine and Therapeutics Dovepress
submit your manuscript | www.dovepress.com
Dovepress 
17
R e v i e w
open access to scientific and medical research
Open Access Full Text Article
http://dx.doi.org/10.2147/AHMT.S15947
Relationships between urinary biomarkers  
of phytoestrogens, phthalates, phenols,  




1Department of Biology, Adelphi 
University, One South Avenue, Garden 
City; 2Department of Biological 
Sciences, New York City College of 
Technology, New York, NY, USA
Correspondence: Tandra R Chakraborty 
Department of Biology, Adelphi  
University, One South Avenue,  
Garden City, New York, NY, USA 
Tel +1 516 877 4202 
Fax +1 516 877 4209 
email chakraborty@adelphi.edu
Abstract: Phytoestrogens, phthalates, and phenols are estrogen-disrupting chemicals that have 
a pronounced effect at puberty. They are exogenous chemicals that are either plant-derived or 
man-made, and can alter the functions of the endocrine system and cause various health defects 
by interfering with the synthesis, metabolism, binding, or cellular responses of natural  estrogens. 
Phytoestrogens, phthalates, and phenols are some of the potent estrogens detectable in urine. 
Phytoestrogens are plant-derived xenestrogens found in a wide variety of food products, like 
soy-based food, beverages, several fruits, and vegetables. Exposure to phytoestrogens can 
delay breast development and further lead to precocious puberty. The effect of phytoestrogens 
is mediated through estrogen receptors α and β or by binding with early immediate genes, such 
as jun and fos. Phthalates are multifunctional synthetic chemicals used in plastics, polyvinyl 
chloride products, cosmetics, hair spray, and children’s toys. Phthalates have been shown to 
cause defeminization, thelarche, precocious puberty, and an increase in breast and pubic hair in 
pubertal girls. However, reports are also available that show no association of phthalates with 
precocious puberty in girls. Phthalates can act through a receptor-mediated signaling pathway or 
affect the production of luteinizing hormone and follicle-stimulating hormone that has a direct 
effect on estrogen formation. Phenols like bisphenol A are industrial chemicals used mainly in 
the manufacture of polycarbonates and plastic materials. Bisphenol A has been shown to cause 
precocious puberty and earlier menarche in pubertal girls. Reports suggest that the neurotoxic 
effect of bisphenol A can be mediated either by competing with estradiol for binding with estro-
gen receptors or via the ERK/NK-kappa or ERRγ pathway. This review demonstrates the effects 
of phytoestrogens, phthalates, and phenols on the development of girls during puberty.
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Introduction
Recent reports have shown that the onset of puberty in girls is much earlier than in 
the past. This may be due to direct or indirect exposure to many hormonally active 
agents that are widely available in the environment.1 These agents are known as 
endocrine-disrupting chemicals (EDCs). EDCs are present in pesticides, textiles, 
flame retardants, plastics, fragrances, detergents, lotions, paints, toiletries, food, and 
other products.2,3 The relationship between exposure to these EDCs and their effect 
on sexual development in girls was studied by observing metabolite content in  various 
urine samples of prepubertal girls.4,5 The three most potent urinary biomarkers of EDC 
are phytoestrogens, phthalates, and phenols, that are estrogenic and affect the human 
body. It has been reported that, because EDCs are used in everyday life and are  easily 
available, the effect of these environmentally active reagents is most pronounced 
during puberty.6







The onset of puberty in girls is mainly governed by increased 
levels of hypothalamic gonadotropin-releasing hormone.7 
Gonadotropin-releasing hormone triggers the secretion of 
luteinizing hormone and follicle-stimulating hormone from 
the anterior pituitary gland, which in turn causes the ova-
ries to respond and secrete estradiol (Figure 1). Estradiol 
then causes differential genetic expression via activation 
of nuclear estrogen receptors α and β (ERα and ERβ) or a 
third receptor (either a plasma membrane-bound receptor or 
a cytoplasmic receptor).8 This results in secondary sexual 
characteristics and eventually the beginning of  menses.9 
The hypothalamic-pituitary-gonadal axis increases in 
activity during puberty but remains functional at all stages 
throughout life.
In 1969, James Tanner10 defined a scale based on the 
physical characteristics and development pattern in children, 
adolescents, and adults (Table 1). The scale, when used for 
females, is based on primary and secondary sex characteris-
tics, like breast size and pubic hair development. If a girl is 
found to have Tanner stage 2 or higher breast development 
(B2+), pubic hair development (PH2+), beginning of menses, 
or axillary hair stage 2 or higher (axillary hair development 
is not described in Tanner staging; in the cited study stage 1 
is absence of axillary hair, stage 2 is sparse, and stage 3 is 
mature), she is considered to be undergoing puberty.11  Tanner 
staging has for the most part been the norm for visual pubertal 
staging of girls.
Estrogen and puberty
Estrogen, a primary female sex hormone secreted mainly 
from the ovaries, is crucial for the sexual differentiation 
that takes place in the prenatal as well as the pubertal stage. 
Estradiol levels have shown to affect bone and brain matura-
tion in both girls and boys. It also has a remarkable effect 
on breast development in girls during puberty. The timing of 
the growth spurt in pubertal girls is also related to estrogen. 
Studies have shown that male and female individuals with 
mutations of estrogen receptors show incomplete linear 
epiphyseal growth, normal skeletal proportions, and lower 
bone mineralization. Estrogen represses growth by closing 
the epiphyses in puberty.7 In both males and females, estrogen 
continues to assist maturation of sexual characteristics even 
after puberty.9
Establishing a trend
In the middle ages, pubertal development occurred at around 
14 years of age. In the 1800s, pubertal changes were seen 
to begin at around 17 years (Table 2).12 Evidently, before 
the last century, scientific standards for measuring pubertal 
development were not as strong as they are now. A pattern of 
decreasing age at onset of thelarche, pubarche, and menarche 
is seen in the US and Europe1 (Figure 2A and B). As of 1997, 
in the US, the average age of B2+ attainment for African-
American girls was 8.87 years and for Caucasian girls was 
9.96 years. African-American girls experienced menarche 
at 12.16 years, and Caucasians at 12.88 years.11,13 In 2002, 
another study indicated that African-American girls in the US 
started menses at 12.1 years, Caucasian girls at 12.7 years, 
and Mexican girls at 12.2 years. It also indicated that 49.4% 
of African-American girls showed breast development at 
9 years of age compared with 15.8% for Caucasian girls and 
24.5% for Mexican girls.14 It was concluded that the mean 
age of onset of puberty has been decreasing for decades 
(Figure 2A and B).1,11,14,15 By analyzing US data, a panel 
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Figure 1 effects of eDCs on the hypothalamic-pituitary-gondal (HPG) axis.
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concluded that there was a notable shift toward earlier ages 
for onset of thelarche and menarche between 1940 and 1994, 
and that it varied according to race/ethnicity.16 This may be 
a result of industrialization, an occurrence that has led to a 
precipitous increase in human exposure to plastics, building 
materials, pharmaceuticals, fertilizers, pesticides, hormones, 
and a myriad other things produced in high quantities during 
an era of synthetic industry.
Endocrine-disrupting chemicals
EDCs are exogenous substances that can be of plant, animal, 
or man-made origin. They are structurally and function-
ally similar to hormones and have the capacity to interfere 
with hormone receptor binding by blocking or mimicking 
hormone signaling pathways through their receptors. In 
2005, the US Environmental Protection Agency discovered 
that less than 7% of 3000 chemicals produced at more than 
1 million lbs per year did not have the complete set of six 
basic toxicity tests and that 43% underwent none of the six 
basic tests (acute toxicity, chronic toxicity, developmental 
and reproductive toxicity, mutagenicity, ecotoxicity, and 
environmental fate).2 Any number of these chemicals can 
be considered as EDC if they disrupt hormonal pathways. 
Most of these chemicals are estrogenic or antiandrogenic 
chemicals. They have a wide range of influence in animals 
as well as in humans.9,16
To detect the presence of EDCs in an organism, their unique 
metabolites are looked for in tissue and urine samples. Various 
studies are conducted to determine which metabolites can be 
considered as accurate biomarkers.17 Urinary biomarkers are 
particularly useful in identifying the presence of EDCs due to 
the relative ease of detecting their metabolites in urine. Because 
urine has a higher concentration of polar metabolites than 
other testable samples and is easy to collect, it is considered 
a good source for detection.4 Some of the potent synthetic 
estrogens detectable in urine are phytoestrogens, phthalates, 
Table 1 Tanner stages of pubic hair and breast rating10
Age (years) Pubic hair Breast
Tanner i <10 No pubic hair No glandular tissue, areola follows the skin contours 
of the chest, elevation of papilla only
Tanner ii 10–11.5 Small amount of long, pigmented, downy hair,  
straight or slightly curled hair along the labia majora
Breast bud forms with a small area of surrounding  
glandular tissue, elevation of breast and papilla,  
areola begins to increase in diameter
Tanner iii 11.5–13 Hair becomes darker, rough and curly.  
Some hair is also found over the junction of the pubis
Breast begins to become more elevated and extends 
beyond the borders of the areola, which takes the  
shape of the breast
Tanner iv 13–15 Adult like hair quality in a small and limited area.  
There is sparing hair in the medial thighs
increased breast size and elevation, areola  
and papilla form a secondary mound projecting  
above of the level of the breast
Tanner v 15+ Adult hair quality which extends to medial surface  
of the thighs in the shape of an inverse triangle
Breast reaches adult final size, areola regresses  
to the general contour of the breast
Table 2 Changes in pubertal age with race and ethnicity12
Race/ethnicity Avg. age 
at menarche
Avg. age 




at breast stage 2+
Year of publication
US
 African-American 12.16 8.87 1997
 Caucasian 12.88 9.96 1997
 NHANeSiii 12.5 9.7 2001
europe
 Netherlands 10.5 1985
 england 11.2 1970
 Spain 12.9 ± 0.2 2000
 Sweden 13.0 1986
 Germany 13.30 1984
 Turkey 13.28 ± 1.09 1996
 Overall 12.5 - 13.1 1998
Asia
 india 12.8 - 14.4 1965
Note: The year of publication refers to the studies done in different counties over the past years on the effect of eDC on puberty. The year designates how far back we 
have gone back or how recent these data are.
Abbreviations: eDC, endocrine-disrupting chemicals; NHANeSiii, National Health and Nutrition examination survey the third -1991–1994.





phenols, polychlorinated biphenyls,  polybrominated 
biphenyls, and DDT.9 Of these, the highest priority urinary 
exposure biomarkers identified by the The Breast Cancer and 
Environment Research Centers consortium are phytoestrogens, 
phthalates, and phenols. These were selected because they had 
hormonal activity and can act as agonists or antagonists.18,19 If 
present in significantly high amounts, they have the potential 
to disrupt homeostasis,20 and have adequate interindividual 
variability to be detected as markers.4
Mechanism of EDC action
EDCs interfere with hormonal pathways by mimicking a 
hormone, by blocking a hormone receptor, and by altering the 
production, metabolism, transportation, release,  elimination, 
and the binding ability of endogenous hormones.16 
EDCs can be estrogenic, antiestrogenic, antiandrogenic, 
 cytokines, thyroid modulators, growth factor modulators, 
or  hormone metabolism modulators.3 An EDC may bind to 
a  membrane-bound receptor, a cytoplasmic receptor, and/
or a nuclear receptor. This in turn prompts differential gene 
expression. Common nuclear receptors that are targeted 
by EDCs include ERα, ERβ, the androgen receptor, aryl 
hydrocarbon receptor, progesterone receptor, glucocorticoid 
receptor, and pregnane-X-R.3
Estrogen-like EDCs have a molecular structure (or part of 
its structure) similar to that of estrogen and disrupt estrogenic 
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Figure 2 (A) Average ages of girls at B2+, PH2+, and menarche in US from 1948–1994.1 (B) Average ages of girls at B2+, PH2+, and menarche in europe from 1965–2009.1
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pathways by altering the feedback mechanisms in central or 
peripheral tissues. Estrogen-like EDCs exert their effects 
on ERα, ERβ, and the aryl hydrocarbon receptor. Estrogen 
binds with the estrogen receptor, dimerizes, and interacts 
with DNA response elements and modulates the expression 
of specific target genes. Estrogen receptors may indirectly 
stimulate gene expression by activating other transcription 
factors instead, such as Sp1 or AP-1, or avert gene activat-
ing methods by activating cytoplasmic molecules, such as 
mitogen-activated protein kinase, to incite rapid signaling.8 
The hydrocarbon structures and halide contents of estrogen-
like EDCs may be a factor accounting for why they can 
bind to the two nuclear receptors, ERα and ERβ. Not only 
do EDCs bind with estrogen receptors but they may have 
higher affinity for estrogen receptors than for endogenous 
estrogen.8,21 This further increases the risk to human health 
of EDC exposure.
Estrogen receptors have particularly high affinity for 
 xenestrogens, even more than endogenous estrogen, because 
of the molecular nature of the ligand-binding pocket. 
 Estrogen receptors have three domains, ie, A/B, C, and D/E. 
The D/E domain is the ligand-binding domain. The C domain 
acts as the hinge region and the DNA binding domain. The 
receptive part of the estrogen receptor responds to an overall 
ring structure, which is a characteristic feature of estrogen 
and xenestrogens.8,9 The aryl hydrocarbon receptor is a 
transcription factor of the Per-ARNT-SIM (bHLH-PAS) 
helix-loop-helix super family. When a ligand binds to it, 
it transports itself to the nucleus of the cell and dimerizes 
with aryl hydrocarbon receptor nuclear translocator. The 
dimer then stimulates expression of genes involved in the 
metabolism of exogenous and some endogenous compounds. 
Aryl hydrocarbon receptor pathways, interestingly, are noted 
to be intertwined at times with estrogen receptor pathways 
and possibly act as an estrogen receptor regulator.8
Precocious puberty
In precocious puberty, the pubertal changes occur earlier 
than expected,22 ie, earlier appearance of secondary sex 
characteristics such as breast development, growth of pubic 
hair, and earlier menarche and thelarche. More precisely, 
if the thelarche occurs before 8 years of age or menarche 
before 9 years of age, the girl is considered to have preco-
cious puberty.14 Puberty at an earlier age causes physi-
ological changes like preparedness for sexual readiness and 
childbearing ability. Since pubertal girls are psychologically 
immature, they are prone to making wrong decisions which 
may negatively impact society. Changes in pubertal timing 
can also cause several physical and physiological diseases. 
Precocious puberty can also lead to early diagnosis of breast 
cancer23 and adult obesity.24 With early puberty, there is a risk 
of accelerated bone maturation and short height, behavioral 
disorders, and psychological problems.
Precocious puberty can be of two types, ie,  peripheral 
 precocious puberty and central precocious puberty.  Peripheral 
precocious puberty results from sex  steroid release by a process 
other than activation of the  hypothalamic-pituitary-gonadal 
axis like ovaries, adrenal glands, and/or the pituitary 
gland. Central precocious puberty is pubertal development 
due to early stimulation of the hypothalamus to release 
gonadotropin-releasing hormone into the hypothalamic-
pituitary-gonadal axis. Peripheral precocious puberty has 
been associated with xenestrogens, while the association 
of central precocious puberty and xenestrogens remains 
 uncertain.3 Premature thelarche can be the first sign of 
precocious puberty. Premature thelarche is isolated breast 
development without pubic or axillary hair development 
before 8 years of age. A higher level of follicle-stimulating 
hormone is seen in girls exhibiting premature thelarche. 
Another condition, known as exaggerated thelarche, involves 
precocious breast development without axial hair or pubic 
hair development, but with an increased overall growth 
rate and advanced bone development.25 Central precocious 
puberty occurs in girls 10 times more often than in boys. It 
is estimated that 10%–20% of girls show precocious puberty 
because of physical brain abnormalities.1
Factors influencing precocious  
puberty
Many factors have attributed to a decrease in the age of 
menarche, thelarche, and pubarche. A positive correlation 
between body mass index and onset of puberty is believed 
to contribute to the trend and to some of the racial/ethnic 
differences. Girls with a higher body mass index typically 
exhibit earlier onset of puberty. It has been observed that 
many African-American girls have a higher body mass 
index than Caucasian girls, which can contribute to racial/
ethnic differences in puberty.9,12,14 Higher birth weight was 
seen to be correlated with earlier onset of puberty.9 Genetics 
also play a role in the onset of puberty. A Finnish study of 
1928 twin boys and 2309 twin girls concluded that genetics 
accounted for 86% of differences in pubertal timing for boys 
and 82% for girls.16 Illness and physical injury particularly 
in the hypothalamus and endocrine functional areas can 
lead to earlier or delayed puberty in girls.9 Organic com-
pounds containing heavy metals and EDCs that can cause 





an  indirect effect, such as triphenyltin, have been shown to 
delay puberty in higher concentrations or cause precocious 
puberty at smaller doses. It can delay puberty or trigger it by 
inhibiting enzymes or interfering with molecules involved 
in the hypothalamic-pituitary-gonadal axis.9,16
Phytoestrogens
Phytoestrogens are plant-derived xenestrogens found in a 
wide variety of food products. They belong to the polyphe-
nolic group of compounds. There are three major classes of 
phytoestrogens. These are isoflavones (genistein, diadzein, 
biochanin),26 lignans (enterolactone, enterodiol),27 and 
coumestans.28 The two major chemical classes of phyto-
estrogens found in the human diet are isoflavones and lignans. 
Phytoestrogens are found mostly in citrus fruit, cherries, 
berries, apples, grapes, celery, capsicum, broccoli, onions, 
tomatoes, red wine, flaxseeds, grains, nuts, chocolate, green 
tea, soya bean, legumes, clover, alfalfa, and spinach. Diadzein 
and genistein are the two best known isoflavones, and are 
found in soy-based food and beverages. Phytoestrogens have 
long been associated with a reduction in risk of osteoporosis, 
heart disease, breast cancer, and menopausal symptoms.
Recently, phytoestrogens have been found to affect 
the timing of puberty, which can disrupt the ability to 
produce viable fertile offspring, sex-specific behavior, and 
fertility in animals.29–31 Genistein when given to CD1 mice 
in the  neonatal period at low doses (0.5 and 5.0 mg/kg) 
has been shown to advance puberty and mammary gland 
 morphogenesis. When given at high doses (50 mg/kg), 
genistein causes delayed mammary gland morphogenesis. 
Further, genistein at 0.5 mg/kg causes increased ovulation 
when compared with controls, and at 50 mg/kg decreases 
ovulation. Fortes et al32 reported a case study of precocious 
thelarche occurring very early in a girl due to excessive intake 
of phytoestrogens in the form of soy. When the soy intake was 
reduced, the girl showed a bone and chronological age for 
puberty  development similar to that of girls on a regular diet.32 
Exposure to phytoestrogens in different regions of the US 
was studied in 1151 girls using urinary biomarkers. Among 
the three EDCs ( phytoestrogens,  phthalates, and  phenols) 
studied, phytoestrogens as a group were present in the high-
est concentrations. All six phytoestrogens ( enterolactone, 
genistein, diadzein, equol, enterodiol, O-DMA) were 
detected in more than 98% of the samples collected. The 
highest concentration among the six phytoestrogens was for 
enterolactone.  Exposure to different phytoestrogens varied 
according to race/ethnicity, site, and body mass index. 
Enterolactone exposure was higher in girls with a lower 
body mass index than in those with a higher body mass 
index. Increased exposure to diadzein and genistein delayed 
breast development in pubertal girls.4 Another study done in 
227 girls showed that when isoflavone was added to the diet 
of healthy white children, breast development (Tanner 2) 
was delayed by 0.7 years compared with girls having a low 
isoflavone diet.26
Further, the same research group reported an  association 
between urinary isoflavone and puberty. A study of 
192 healthy 9-year-old girls in inner New York City showed 
that intake of dietary phytoestrogens was not significantly 
related to breast development.33 Urinary phytoestrogen 
biomarker concentrations were lower in girls with breast 
development than in those with no breast development. 
Breast development had a significant relationship with body 
mass index. Because adipose tissue is a source of  peripubertal 
hormones, it is important to take body mass index into 
 consideration. There was a delay in breast development in 
girls with body mass index below the median and high levels 
of urinary diadzein, and girls with a higher or median body 
mass index showed a similar effect on exposure to genistein. 
The effect of urinary enterolactone was seen only in girls 
with high body mass index. Girls with high urinary entero-
lactone had delayed breast development, but no effect on 
 development of pubic hair was noted on EDC exposure.34
Mechanism
Phytoestrogens have been shown to inhibit pathways of 
cell growth and proliferation, and to affect multiple organ 
systems.35 Recently, phytoestrogens have been found to have 
effects similar to those of man-made EDCs. When phyto-
estrogens are ingested, they can be metabolized by gut flora 
(intestinal bacteria) in the large intestine into the mamma-
lian lignans, enterodiol and enterolactone. These metabolic 
products are then excreted directly in the feces after being 
absorbed from the gut or reabsorbed from the intestine. They 
are eventually excreted in a conjugated form36 and can be 
detected in urine.
The structural similarities between the phenolic ring 
of phytoestrogens and estrogen enable phytoestrogens to 
bind to estrogen receptors. Phytoestrogens have been found 
to bind to both ERα and ERβ and to activate estrogen 
 receptor-dependent gene transcription through both  subtypes, 
have relatively higher binding affinity for ERα than for 
ERβ,37,38 and to bind with early immediate genes, such as 
jun and fos.39 Another hormone which is of importance is 
 progesterone.  Progesterone is important for differentiation of 
the  mammary gland. The mammary gland is rudimentary at 
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birth and progresses with puberty with the influx of estrogen 
and progesterone. It has been speculated that  phytoestrogens 
block progesterone action in a significant manner. The 
effect of phytoestrogens on mammary gland development 
could involve blocking of the progesterone receptor or the 
 combined effect of estrogen and progesterone.40
Phthalates
Phthalates are multifunctional synthetic chemicals used in 
a variety of consumer products. They are oily, colorless, 
odorless liquids that do not evaporate readily. Higher 
molecular weight phthalates, ie, di-(2-ethylhexyl) phthalates 
(DEHP), di- isodecyl phthalate, and di-isononyl phthalate, are 
produced in high volumes for use in construction materials, 
clothing, children’s toys, and household furnishings. Low 
molecular weight phthalates, like di-n-butyl phthalate, diethyl 
phthalate, and dimethyl phthalate, are mainly used as solvents 
and in adhesives, waxes, inks, cosmetics, insecticides, and 
 pharmaceuticals. They are found in the environment in high 
and low molecular weight forms. The US and Canada have 
now banned use of DEHP in the making of pacifiers for 
children, but it is still used to make soft-squeeze toys. In 
the medical industry, use of phthalates continues in tubing, 
blood bags, dialysis equipment, and disposable medical 
examination gloves.
Humans are exposed to phthalates on a daily basis 
due to their widespread production and use. Phthalates 
have been shown to cause defeminization, thelarche, and 
early secondary breast development in pubertal girls.41 
Reports have shown that phthalates can cause toxicity to 
the fetus and have a significant effect on development and 
 reproduction. Exposure to phthalates causes females to grow 
more  rapidly and causes onset of puberty at an earlier age, 
and the overall height at adulthood of these females may 
be shorter than others.14 Studies done in China showed that 
girls with  precocious puberty had higher serum DEHP levels 
than girls with onset of puberty at the normal age. These 
girls had a significantly larger ovarian and uterus size than 
a control group.42 In Puerto Rico, girls aged 8 months to 
8 years were shown to have thelarche on serum exposure to 
phthalates.41 However, examination of urinary biomarkers 
for phthalates in US girls showed no difference between 
girls with precocious puberty and a control group.43 Studies 
in 1151 girls aged 6–8 years from New York City, greater 
Cincinnati, Ohio, and northern California showed that higher 
intake of low molecular weight phthalates increased both 
breast and pubic hair development. On the other hand, an 
inverse relationship was found with high molecular weight 
phthalates and pubic hair development.5 The differences in 
results reported by different research groups could be due 
to the different locations of the studies, ethnicity, age, or a 
cumulative effect of other EDCs.
Mechanism
Exposure to phthalates occurs via ingestion, inhalation, 
intravenous injection tubing and solutions, and skin 
 absorption. When phthalates are leached from one product 
into another, they can have a direct and more drastic effect. 
Chemicals contained in these products are absorbed through 
the skin, and then enter the bloodstream. Upon reaching the 
intestine, diester phthalates are hydrolyzed into monoester 
phthalates.44 Short-branched phthalates (eg, diethyl phthalate 
and dimethyl phthalate) are excreted mainly in the urine as 
monoester phthalates, while the more long-branched phtha-
lates (eg, DEHP) undergo further hydroxylation and oxida-
tion before they are excreted in urine and feces.44 There have 
been several mechanisms cited for the action of phthalates 
on reproduction: they can act through a receptor-mediated 
signaling pathway to suppress estradiol production in the 
ovary leading to anovulation; they have also been shown 
to affect production of luteinizing hormone and follicle-
stimulating hormone which have a direct effect on estrogen 
formation;45 and by activation of peroxisome proliferation-
activated receptors, causing decreased estradiol synthesis, 
and increased estradiol metabolism, causing suppressed 
estradiol levels.45
Phenols
Phenols are weakly acidic, water-soluble organic chemical 
compounds related to phenol. Phenols are industrial chemicals 
used mainly to manufacture polycarbonates and plastic 
materials. The more commonly studied phenols are bisphenol 
A and alkyl phenols. Other phenols that are thought to have 
EDC effects are benzophenone-3, 2,5-dichlorophenol, 
triclosan, and parabens.5,46,47 Phenols are commonly found in 
Tupperware™ products, baby bottles, polycarbonate bottles, 
food cans, microwave containers, dental sealants, medical 
products, and plastic tubing.9,33,47–49 Alkyl phenol ethoxylates 
are used as surfactants in detergents, disinfectants, surface 
cleaners, and pesticides. Tris(nonylphenol) phosphite is also 
used as a plasticizer.2,47 Parabens is used in preservatives and 
microbicides. It is typically found in jellies, syrups, baked 
goods, drinks, shampoos, deodorants, hairsprays, cosmetics, 
and pharmaceuticals.2 1,4-dichlorobenzene, which is 
metabolized to 2,5-dichlorophenol, is found in deodorizers and 
mothballs. Benzophenone-3 is typically found in sunscreens. 





Triclosan acts as a microbicide and is likely to be found in a 
wide variety of consumer products.5,34
Other important routes for exposure to phenols include 
ingestion, dermal absorption, and inhalation.2,46,48,49 
At high temperatures, polymers containing bisphenol A in 
canned foods, plastic containers, and polycarbonate bottles 
hydrolyze, allowing bisphenol A to leech out.47,49 It takes 
about 24 hours for bisphenol A to be excreted from the 
body, mainly in the form of a glucuronide conjugate.47,48 
Because bisphenol A accumulates in the body, the full 
amount of bisphenol A intake may not correspond to urinary 
bisphenol A metabolite levels.2,46,47 Nonylphenol is thought 
to be excreted within 8 hours of ingestion, be metabolized to 
glucuronide, or sulfated and then excreted in urine.47,50
In animal models, it has been shown that prenatal 
alkyl phenol exposure causes increased or decreased birth 
weight in rodents.51,52 It was seen to affect the estrus cycle, 
pubertal onset, mammary gland development, brain sexual 
 differentiation, and cell division by meiosis.47 The  metabolite, 
2,5-dichlorophenol, causes lower birth weight in rats.53 
A pilot study completed in November 2006 examined uri-
nary  biomarkers in 90 peripubertal Asian, Black, Hispanic, 
and White girls to determine exposure to three chemical 
families, ie, phyto estrogens, phthalate, and phenols. Nine 
phenols were sampled. Phenols had the lowest concentrations 
of the three chemical families sampled. Three of the nine 
phenols (ie, bisphenol A, benzophenone-3, and 2,5-dichlo-
rophenol) were detected in more than 94% of the samples 
collected. The  highest  concentration was for benzophenone-3. 
 Benzophenone-3 levels were higher in Whites and 2,5-dichlo-
rophenol levels were higher in Blacks. Benzophenone-3 was 
higher in samples collected in summer. In women, 2,5-dichlo-
rophenol and benzophenone-3 exposure has been associated 
with reduced or increased birth weight. 2,5-dichlorophenol 
seems to promote breast development in girls with high body 
mass index, but the relationship is nullified after stratifying 
for body mass index. Exposure to benzophenone-3 causes an 
increase in breast development in girls with a low body mass 
index and has an opposite effect in girls with high body mass 
index.5 Triclosan seems to have an inverse relationship with 
development of pubic hair. Of all the phenols identified so 
far, bisphenol A is produced in the highest quantities. It has 
been linked with liver damage,54,55 diabetes, and cardiovas-
cular disease.56 In animals, bisphenol A can cause damage 
and malfunction of the reproductive organs, a decline in the 
quality of embryos, and increased cell proliferation in females. 
Bisphenol A has been shown to cause disruption of pubertal 
timing in female rats. Female rats exposed to 50 µg/kg of 
bisphenol A for first 4 days show an advanced pubertal timing, 
whereas higher doses delayed it.27 A similar trend has been 
observed in industrialized nations. Children aged 6–11 years 
have been shown to have the highest urinary concentrations of 
bisphenol A than any other age group studied.57 Bisphenol A 
was shown to cause precocious puberty in pubertal girls 
and an increase in genital abnormalities in boys.58  Minority 
populations in the US have shown delayed menarche when 
exposed to bisphenol A. Similar results have been reported 
in Europe, and in girls who are adopted and move from 
developing to industrialized countries.12 Studies have shown 
that postnatal exposure of rats to bisphenol A at low doses 
decreases basal luteinizing hormone secretion, alters the 
estrus cycle, increases  gonadotropin-releasing hormone pul-
satility, and at higher doses, causes precocious puberty and a 
persistent estrus phase.49 A study in 1151 girls aged 6–8 years 
from New York City, greater Cincinnati, Ohio, and northern 
California showed that benzophenone-3 increased breast 
development in girls with low body mass index and had an 
opposite effect in girls with high body mass index. Further, 
this study concluded that phenols were associated with 
pubertal timing.5
Mechanism
Phenols are well absorbed from the gastrointestinal tract and 
through the skin. They are metabolized to quinone-related 
reactive intermediates, which bind covalently to protein 
and are detoxified by conjugation with glutathione. Most of 
the absorbed phenol and its metabolites are excreted in the 
urine. There are differences in scientific opinion regarding 
the mechanism of action of phenols. Reports suggest that the 
neurotoxic effects of bisphenol A can be mediated either by 
competing with estradiol for binding with estrogen receptors59 
or through the ERK/NK-kappa60/ERRγ61 pathway, which is 
an indirect pathway of estrogen action through its membrane 
receptor. The actions of bisphenol A are less potent than those 
of estrogen, and act antagonistically on peroxidase activity in 
the presence of estrogen.62 Alkyl phenols also mimic estrogen, 
and are believed to act through other endocrine pathways as 
well.2 However, bisphenol A and alkyl phenols are less potent 
than estrogen itself.2
Conclusion
It appears that phytoestrogens, phthalates, and phenols all 
affect the timing of puberty, thelache, and menarche, lead-
ing to precocious puberty. Precocious puberty can result 
in diseases such as obesity, diabetes, and cancer, and has 
psychological consequences. Because EDCs are easily 
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available and present in products that are used in day-to-day 
life, it is the social responsibility of all individuals to be 
aware of the consequences and educate their children about 
how to adapt to an earlier age of sexual maturity. Although 
there are many government-driven biomonitoring programs 
in progress, research should be focused not only on under-
standing the risks involved in exposure to these agents, but 
also on preventative strategies. Use of these compounds 
should be limited as far as possible. Future studies need to 
be conducted in order to reveal the exact actions of EDCs, 
how they may be removed or contained in our environment, 
and limit further health risks.
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